JNJ
Johnson & Johnson
$259.29
▼ -1.43%
−$3.75
NYSE · Healthcare · Drug Manufacturers - General
Johnson & Johnson
JNJ · NYSE · Healthcare · Drug Manufacturers - General
$259.29
▼ -1.43% · −$3.75 today
fundamentals55 /100 vs peers
weak
Revenue growth (TTM)7.9
45% below Sector 5Y avg avgSector 5Y avg: 14.4
EPS growth (TTM)-3.6
131% below Sector 5Y avg avgSector 5Y avg: 11.6
EPS forecast (5Y)9.2
37% below Sector fwd avg avgSector fwd avg: 14.5
EPS next year10.3
solid pace
EPS growth (Q/Q)-52.8
weak pace
Compared against sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| JNJJohnson & Johnson | $624.17B | 30.0 | +7.9% | 55 |
| INDVIndivior | $4.85B | 20.2 | +10.3% | 81 |
| GMEDGlobus Medical | $10.87B | 18.7 | +23.5% | 78 |
| DXCMDexcom | $27.49B | 30.5 | +16.1% | 78 |
| LLYEli Lilly and Company | $1.14T | 43.7 | +47.4% | 77 |
